Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
6 April 2025
|
|
N 18:08 | Elafibranor 14 changes history +43,961 [Parth Vikram Singh (14×)] | |||
|
|
18:08 (cur | prev) −78 Parth Vikram Singh talk contribs | ||||
|
|
17:57 (cur | prev) +24 Parth Vikram Singh talk contribs | ||||
|
|
17:54 (cur | prev) +26 Parth Vikram Singh talk contribs | ||||
|
|
17:43 (cur | prev) +9,680 Parth Vikram Singh talk contribs | ||||
|
|
17:31 (cur | prev) −11 Parth Vikram Singh talk contribs | ||||
|
|
17:23 (cur | prev) +14,775 Parth Vikram Singh talk contribs | ||||
|
|
13:54 (cur | prev) +155 Parth Vikram Singh talk contribs | ||||
|
|
13:32 (cur | prev) +2,473 Parth Vikram Singh talk contribs | ||||
|
|
13:27 (cur | prev) +3,367 Parth Vikram Singh talk contribs | ||||
|
|
13:24 (cur | prev) +2,210 Parth Vikram Singh talk contribs | ||||
|
|
13:08 (cur | prev) +110 Parth Vikram Singh talk contribs | ||||
|
|
13:06 (cur | prev) +9,598 Parth Vikram Singh talk contribs | ||||
|
|
11:52 (cur | prev) +672 Parth Vikram Singh talk contribs | ||||
| N |
|
10:33 (cur | prev) +960 Parth Vikram Singh talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Parth Vikram Singh |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Elafibranor in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-...") | |||
2 April 2025
|
|
17:11 | Seladelpar 10 changes history +33,129 [Parth Vikram Singh (10×)] | |||
|
|
17:11 (cur | prev) +3 Parth Vikram Singh talk contribs | ||||
|
|
17:08 (cur | prev) +274 Parth Vikram Singh talk contribs | ||||
|
|
16:40 (cur | prev) +375 Parth Vikram Singh talk contribs | ||||
|
|
11:41 (cur | prev) +2,447 Parth Vikram Singh talk contribs | ||||
|
|
11:28 (cur | prev) +10,282 Parth Vikram Singh talk contribs | ||||
|
|
11:04 (cur | prev) +7,303 Parth Vikram Singh talk contribs | ||||
|
|
08:28 (cur | prev) +2,266 Parth Vikram Singh talk contribs | ||||
|
|
07:58 (cur | prev) +8,538 Parth Vikram Singh talk contribs | ||||
|
|
07:27 (cur | prev) +824 Parth Vikram Singh talk contribs | ||||
|
|
06:54 (cur | prev) +817 Parth Vikram Singh talk contribs | ||||
1 April 2025
| N 11:28 | Seladelpar diffhist +3,541 Parth Vikram Singh talk contribs (Created page with "{{DrugProjectFormSinglePage |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Seladelpar in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-Supported Use'' of Seladelpar i...") | ||||